The effect of iron in MRI and transverse relaxation of amyloid‐beta plaques in Alzheimer's disease

Dysregulation of neural iron is known to occur during the progression of Alzheimer's disease. The visualization of amyloid‐beta (Aβ) plaques with MRI has largely been credited to rapid proton relaxation in the vicinity of plaques as a result of focal iron deposition. The goal of this work was to determine the relationship between local relaxation and related focal iron content associated with Aβ plaques. Alzheimer's disease (n = 5) and control tissue (n = 3) sample slices from the entorhinal cortex were treated overnight with the iron chelator deferoxamine or saline, and microscopic gradient‐echo MRI datasets were taken. Subsequent to imaging, the same slices were stained for Aβ and iron, and then compared with regard to parametric R2* relaxation maps and gradient‐echo‐weighted MR images. Aβ plaques in both chelated and unchelated tissue generated MR hypo‐intensities and showed relaxation rates significantly greater than the surrounding tissue. The transverse relaxation rate associated with amyloid plaques was determined not to be solely a result of iron load, as much of the relaxation associated with Aβ plaques remained following iron chelation. The data indicate a dual relaxation mechanism associated with Aβ plaques, such that iron and plaque composition synergistically produce transverse relaxation.Copyright © 2014 John Wiley & Sons, Ltd.

[1]  Christian Denk,et al.  Susceptibility weighted imaging with multiple echoes , 2010, Journal of magnetic resonance imaging : JMRI.

[2]  C. Jenkins,et al.  Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide β-amyloid. , 2014, Inorganic chemistry.

[3]  Paul M Thompson,et al.  Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[4]  Louise van der Weerd,et al.  MRI artifacts in human brain tissue after prolonged formalin storage , 2011, Magnetic resonance in medicine.

[5]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[6]  W. Moses Fundamental Limits of Spatial Resolution in PET. , 2011, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment.

[7]  J. Kwiatkowski Real-world use of iron chelators. , 2011, Hematology. American Society of Hematology. Education Program.

[8]  Bejoy Thomas,et al.  Principles, techniques, and applications of T2*-based MR imaging and its special applications. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[9]  Clifford R. Jack,et al.  Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain , 2011, NeuroImage.

[10]  G. van der Laan,et al.  Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1–42) , 2014, Journal of The Royal Society Interface.

[11]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[12]  Yi Liu,et al.  Change in knee cartilage T2 at MR imaging after running: a feasibility study. , 2005, Radiology.

[13]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[14]  M. D'Andrea,et al.  Lipofuscin and Aβ42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains , 2002, Neuroscience Letters.

[15]  J. Connor,et al.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.

[16]  R. Scott,et al.  Is hemochromatosis a risk factor for Alzheimer's disease? , 2001, Journal of Alzheimer's disease : JAD.

[17]  Xiongwei Zhu,et al.  Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. , 2004, Journal of Alzheimer's disease : JAD.

[18]  G. Bartzokis Alzheimer's disease as homeostatic responses to age-related myelin breakdown , 2011, Neurobiology of Aging.

[19]  G. Perry,et al.  Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. , 2000, Antioxidants & redox signaling.

[20]  C. Masters,et al.  Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease , 2010, Cell.

[21]  G. Perry,et al.  Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. , 2008, Journal of Alzheimer's disease : JAD.

[22]  J. Dobson,et al.  Redox cycling of iron by Abeta42. , 2006, Free radical biology & medicine.

[23]  G. Fullerton,et al.  The influence of macromolecular polymerization of spin-lattice relaxation of aqueous solutions. , 1987, Magnetic resonance imaging.

[24]  P. Faller,et al.  Iron(II) binding to amyloid-β, the Alzheimer's peptide. , 2011, Inorganic chemistry.

[25]  J. Dobson,et al.  Redox cycling of iron by Aβ42 , 2006 .

[26]  W. Koppenol The Haber-Weiss cycle – 70 years later , 2001, Redox report : communications in free radical research.

[27]  G. Robino,et al.  H2o2 and 4-hydroxynonenal mediate amyloid β-induced neuronal apoptosis by activating jnks and p38mapk , 2003, Experimental Neurology.

[28]  M. D'Andrea,et al.  Lipofuscin and Abeta42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains. , 2002, Neuroscience letters.

[29]  Joseph A. Helpern,et al.  Histological Co-Localization of Iron in Aß Plaques of PS/APP Transgenic Mice , 2005, Neurochemical Research.

[30]  Ryan Chamberlain,et al.  Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease. , 2011, Current medical imaging reviews.

[31]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Q. Pankhurst,et al.  Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[33]  Qing X Yang,et al.  MRI and histological analysis of beta‐amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice , 2009, Journal of magnetic resonance imaging : JMRI.

[34]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[35]  Jan Sedlacik,et al.  Susceptibility weighted imaging at ultra high magnetic field strengths: Theoretical considerations and experimental results , 2008, Magnetic resonance in medicine.

[36]  J. Kehrer The Haber-Weiss reaction and mechanisms of toxicity. , 2000, Toxicology.

[37]  Jian Wang,et al.  Regulation of cellular iron metabolism , 2011, The Biochemical journal.

[38]  Roberto Cappai,et al.  Metals and amyloid‐β in Alzheimer's disease , 2005, International journal of experimental pathology.

[39]  Tobias Jung,et al.  Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells. , 2010, Free radical biology & medicine.

[40]  D. Harman,et al.  Alzheimer's Disease Pathogenesis , 2006, Annals of the New York Academy of Sciences.

[41]  F. Torti,et al.  Response to Oxidative Stress Translational Regulation of Ferritin in Coordinate Transcriptional and , 2000 .

[42]  Christopher M Collins,et al.  Direct magnetic resonance imaging of histological tissue samples at 3.0T , 2007, Magnetic resonance in medicine.

[43]  Mark A. Smith,et al.  In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease , 2000, Journal of neurochemistry.

[44]  Xudong Huang,et al.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.

[45]  W. Klein,et al.  Iron Levels Modulate α‐Secretase Cleavage of Amyloid Precursor Protein , 1995, Journal of neurochemistry.

[46]  W. Markesbery,et al.  Oxidative damage in mild cognitive impairment and early Alzheimer's disease , 2007, Journal of neuroscience research.

[47]  Michael Garwood,et al.  In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent , 2004, Magnetic resonance in medicine.

[48]  A. Bush Metal complexing agents as therapies for Alzheimer’s disease , 2002, Neurobiology of Aging.